Literature DB >> 29370558

Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.

Jing Liu1, Xinyu Qu1, Liwei Shao1, Yuan Hu1, Xin Yu1, Peixiang Lan1, Qie Guo1, Qiuju Han1, Jian Zhang1, Cai Zhang1.   

Abstract

Melanoma is the deadliest form of commonly encountered skin cancer, and has fast propagating and highly invasive characteristics. Pim-3, a highly expressed oncogene in melanoma, is a highly conserved serine/threonine kinase with various biological activities, such as proliferation-accelerating and anti-apoptosis effects on cancer progression. However, whether Pim-3 regulates melanoma metastasis has not been determined. Here, we constructed a Pim-3-silencing short hairpin RNA (sh-Pim-3), a TLR7-stimulating ssRNA and a dual-function vector containing a sh-Pim-3 and a ssRNA, and transfected them into the B16F10 melanoma cell line to investigate the effects of Pim-3 on migration and invasion in melanoma. We found that sh-Pim-3 inhibited B16F10 cell migration and invasion in vitro. In a tumor-bearing mouse model, sh-Pim-3 significantly downregulated pulmonary metastasis of B16F10 melanoma cell in vivo. Mechanistically, sh-Pim-3 inhibited metastasis by regulating the expression of genes related to epithelial-mesenchymal transition (EMT). Further study revealed that by promoting the phosphorylation of STAT3 (signal transducer and activator of transcription 3), Pim-3 induced the expression of Slug, Snail, and ZEB1, which enhanced EMT-related changes and induced melanoma migration and invasion. Our study suggests that Pim-3 is a potential effective target for melanoma therapy.

Entities:  

Keywords:  EMT; Melanoma; Metastasis; Pim-3; p-STAT3

Mesh:

Substances:

Year:  2018        PMID: 29370558      PMCID: PMC5790343          DOI: 10.1080/15384047.2017.1414756

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  41 in total

1.  N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.

Authors:  Myung-Jin Kim; Jihyun Lim; Young Yang; Myeong-Sok Lee; Jong-Seok Lim
Journal:  Cancer Lett       Date:  2014-08-19       Impact factor: 8.679

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.

Authors:  Dapeng Xu; Michael G Cobb; Lily Gavilano; Sam M Witherspoon; Daniel Williams; Catherine D White; Pietro Taverna; Brian K Bednarski; Hong Jin Kim; Albert S Baldwin; Antonio T Baines
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

4.  Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.

Authors:  Deshan Ren; Fei Liu; Guanjun Dong; Ming You; Jianjian Ji; Yahong Huang; Yayi Hou; Hongye Fan
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

5.  Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

Authors:  Bin Liu; Zhen Wang; Hong-Yu Li; Bo Zhang; Bo Ping; Ying-Yi Li
Journal:  Oncol Rep       Date:  2014-04-25       Impact factor: 3.906

6.  MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.

Authors:  Shun Li; Juan Lu; Yu Chen; Niya Xiong; Li Li; Jing Zhang; Hong Yang; Chunhui Wu; Hongjuan Zeng; Yiyao Liu
Journal:  Cell Mol Immunol       Date:  2016-03-21       Impact factor: 11.530

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines.

Authors:  Chifumi Fujii; Yasunari Nakamoto; Peirong Lu; Koichi Tsuneyama; Boryana K Popivanova; Shuichi Kaneko; Naofumi Mukaida
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

9.  Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Authors:  Rahul Purwar; Christoph Schlapbach; Sheng Xiao; Hong Soon Kang; Wassim Elyaman; Xiaodong Jiang; Anton M Jetten; Samia J Khoury; Robert C Fuhlbrigge; Vijay K Kuchroo; Rachael A Clark; Thomas S Kupper
Journal:  Nat Med       Date:  2012-07-08       Impact factor: 53.440

10.  Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.

Authors:  Hui-Hui Cao; Jian-Hong Chu; Hiu-Yee Kwan; Tao Su; Hua Yu; Chi-Yan Cheng; Xiu-Qiong Fu; Hui Guo; Ting Li; Anfernee Kai-Wing Tse; Gui-Xin Chou; Huan-Biao Mo; Zhi-Ling Yu
Journal:  Sci Rep       Date:  2016-02-25       Impact factor: 4.379

View more
  9 in total

1.  The role of DNA methylation in human trophoblast differentiation.

Authors:  Teena K J B Gamage; William Schierding; Daniel Hurley; Peter Tsai; Jackie L Ludgate; Chandrakanth Bhoothpur; Lawrence W Chamley; Robert J Weeks; Erin C Macaulay; Joanna L James
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

Review 2.  PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.

Authors:  Sabina Luszczak; Christopher Kumar; Vignesh Krishna Sathyadevan; Benjamin S Simpson; Kathy A Gately; Hayley C Whitaker; Susan Heavey
Journal:  Signal Transduct Target Ther       Date:  2020-01-31

3.  Long non-coding RNA (FALEC) promotes malignant behaviors of gastric cancer cells by regulating miR-203b/PIM3 axis.

Authors:  Wenjing Dong; Mancheng Gong; Jianjun Xiao; Huifen Li; Muyou Tian; Senming Wang
Journal:  Ann Transl Med       Date:  2022-05

4.  Pim-3 alleviates lipopolysaccharide-stimulated AR42J pancreatic acinar cell injury via improving the inflammatory microenvironment.

Authors:  Jie Jian; Shuang Li; Nian Fang; You-Zhao Cao; Li Zhen; Jian-Bin Qin; Bin Li
Journal:  Exp Ther Med       Date:  2019-10-10       Impact factor: 2.447

5.  Enhanced Anti-melanoma Efficacy of a Pim-3-Targeting Bifunctional Small Hairpin RNA via Single-Stranded RNA-Mediated Activation of Plasmacytoid Dendritic Cells.

Authors:  Jing Liu; Yuan Hu; Qie Guo; Xin Yu; Liwei Shao; Cai Zhang
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

6.  MicroRNA-489-3p plays a significant role in congenital hypothyroidism through regulating neuronal cell apoptosis via targeting translationally controlled tumor protein 1.

Authors:  Qin Liu; Yuehong Li; Yong Zhou
Journal:  Exp Ther Med       Date:  2021-01-20       Impact factor: 2.447

7.  The role of vascular mimicry as a biomarker in malignant melanoma: a systematic review and meta-analysis.

Authors:  Zhenhua Zhang; Saber Imani; Marzieh Dehghan Shasaltaneh; Hossein Hosseinifard; Linglin Zou; Yu Fan; Qinglian Wen
Journal:  BMC Cancer       Date:  2019-11-21       Impact factor: 4.430

Review 8.  Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.

Authors:  Wook Jin
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

Review 9.  PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.

Authors:  Sabina Luszczak; Christopher Kumar; Vignesh Krishna Sathyadevan; Benjamin S Simpson; Kathy A Gately; Hayley C Whitaker; Susan Heavey
Journal:  Signal Transduct Target Ther       Date:  2020-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.